Condition
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) clinical trials that are recruiting, at sites in 26 countries (most in Italy (3), United Kingdom (2), Germany (2)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 26Countries
Newest Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| BPDCN patients treated with chemotherapy: a look back at real-world use | — | Aarhus and 66 other locations | Recruiting | Aug 25, 2026 |
| Tagraxofusp in BPDCN: Real-world Registry of Safety and Effectiveness | — | Innsbruck and 40 other locations | Recruiting | Aug 25, 2026 |
| Tagraxofusp and venetoclax in newly diagnosed BPDCN | Phase 2 | Amiens and 33 other locations | Recruiting | Jun 5, 2025 |
| International registry for Blastic Plasmacytoid Dendritic Cell Neoplasm | — | Miami, Florida and 21 other locations | Recruiting | Jun 24, 2022 |
All recruiting trials (4)
-
BPDCN patients treated with chemotherapy: a look back at real-world use
This study tests how chemotherapy has performed in adults with BPDCN and compares the results to a prospective registry for ELZONRIS.
-
Tagraxofusp in BPDCN: Real-world Registry of Safety and Effectiveness
This registry follows adults with BPDCN to see how tagraxofusp works in everyday clinical practice and how safe it is over time.
-
Tagraxofusp and venetoclax in newly diagnosed BPDCN
This trial tests whether combining tagraxofusp with venetoclax can produce higher complete remissions in adults with newly diagnosed BPDCN.
-
International registry for Blastic Plasmacytoid Dendritic Cell Neoplasm
This study is creating a global database for people with Blastic Plasmacytoid Dendritic Cell Neoplasm to gather information on their experiences and treatments to help improve care for this rare cancer.
Quick answers
How many Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 26 countries. The most sites are in Italy (3 trials), United Kingdom (2 trials), Germany (2 trials), France (2 trials), Armenia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.